Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,710.00
Bid: 1,722.00
Ask: 1,728.00
Change: -60.00 (-3.39%)
Spread: 6.00 (0.348%)
Open: 1,784.00
High: 1,784.00
Low: 1,710.00
Prev. Close: 1,770.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Sep 2009 16:37

RNS Number : 8819Y
Genus PLC
10 September 2009
 



10 September 2009

FOR IMMEDIATE RELEASE 

Genus plc

('Genus' or 'the Company')

Director/PDMR Shareholding

Of 119,386 ordinary shares of 10 pence each in the Company ('Ordinary Shares') that vested today in favour of Richard Wood, Chief Executive, under the Company's Performance Share Plan (the 'Plan'), 60,290 Ordinary Shares are being retained by Richard Wood as part of his shareholding in the Company. 49,096 Ordinary Shares were today sold on behalf of Richard Wood at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Richard Wood as a result of today's vesting and a further 10,000 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Richard Wood.

Richard Wood's direct shareholding in the Company now stands at 120,595 Ordinary Shares which represent 0.203% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 223,710 conditional shares and nil-cost options under the Plan.

Of 68,220 Ordinary Shares that vested today in favour of Ian Biggs, Chief Operating Officer for the Americas, under the Plan, 26,777 Ordinary Shares are being retained by Ian Biggs as part of his shareholding in the Company. 28,055 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Ian Biggs as a result of today's vesting and a further 13,388 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Ian Biggs.

Ian Biggs' direct shareholding in the Company now stands at 30,152 Ordinary Shares which represent 0.051of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 85,932 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer for Europe and The Far East, under the Plan, 16,760 Ordinary Shares are being retained by Thomas Philip Acton as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Thomas Philip Acton as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Thomas Philip Acton.

Thomas Philip Acton's direct shareholding in the Company now stands at 37,864 Ordinary Shares which represent 0.064% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 78,627 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Steve Amies, Chief Operating Officer for Global Research & Product Development, under the Plan, 16,760 Ordinary Shares are being retained by Steve Amies as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Steve Amies at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Steve Amies as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Steve Amies.

Steve Amies' direct shareholding in the Company now stands at 16,760 Ordinary Shares which represent 0.028% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 58,623 conditional shares and nil-cost options under the Plan.

 

For further information please contact:

 

Ian Farrelly Tel: 01256 345996

Group Company Secretary & General Counsel

Genus plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUROVRKBRKAAR
Date   Source Headline
23rd Feb 20167:00 amRNSINTERIM RESULTS
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.